Loading…

Murine chronotoxicity to pharmaceutical wastewater

The present study was undertaken to report the modeling of the dosing-time-dependent adverse effects of both untreated and biologically-treated pharmaceutical wastewater in mice. The mice were housed in a room controlled at 24 °C under a 12 h/12 h dark-light cycle (light 7:00–19:00 h) for two weeks...

Full description

Saved in:
Bibliographic Details
Published in:Biological rhythm research 2014-03, Vol.45 (2), p.167-181
Main Authors: Dridi, Dorra, Bchir, Fatma, Zouiten, Amina, Tahrani, Leyla, Ben Mansour, Hedi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c280t-d67a658976dd771eb82e0ce1f5b2e0a7636076c69f5114a0b1baff1140d392853
container_end_page 181
container_issue 2
container_start_page 167
container_title Biological rhythm research
container_volume 45
creator Dridi, Dorra
Bchir, Fatma
Zouiten, Amina
Tahrani, Leyla
Ben Mansour, Hedi
description The present study was undertaken to report the modeling of the dosing-time-dependent adverse effects of both untreated and biologically-treated pharmaceutical wastewater in mice. The mice were housed in a room controlled at 24 °C under a 12 h/12 h dark-light cycle (light 7:00–19:00 h) for two weeks before initiating the experiments and allowed free access to food and water. A single dose of pharmaceutical or bioremediated effluent was administrated intraperitoneally (10 mL/kg) to mice divided in six circadian stages [1, 5, 9, 13, 17, and 21 hours after light onset (HALO)]. The surviving treated mice exhibited a significant circadian variation in body weight loss (p
doi_str_mv 10.1080/09291016.2013.787684
format article
fullrecord <record><control><sourceid>fao_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_09291016_2013_787684</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US201600079441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-d67a658976dd771eb82e0ce1f5b2e0a7636076c69f5114a0b1baff1140d392853</originalsourceid><addsrcrecordid>eNqFj11LwzAYhYMoOKf_QLB_oPNNmubjSmToFCZe6K7D2zRxla4Zacbcv7ejCt55dc7FeQ48hFxTmFFQcAuaaQpUzBjQYiaVFIqfkAmVnOecSn36p5-Ti77_hGEtgU0Ie9nFpnOZXcfQhRS-GtukQ5ZCtl1j3KB1u9RYbLM99sntMbl4Sc48tr27-skpWT0-vM-f8uXr4nl-v8wtU5DyWkgUpdJS1LWU1FWKObCO-rIaCkpRCJDCCu1LSjlCRSv0fqhQF5qpspgSPv7aGPo-Om-2sdlgPBgK5uhtfr3N0duM3gN2N2JN58NgsA-xrU3CQxuij9jZpjfFPw8344PHYPAjDsDqbRgIAJCac1p8A8sWaAc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Murine chronotoxicity to pharmaceutical wastewater</title><source>Taylor and Francis Science and Technology Collection</source><creator>Dridi, Dorra ; Bchir, Fatma ; Zouiten, Amina ; Tahrani, Leyla ; Ben Mansour, Hedi</creator><creatorcontrib>Dridi, Dorra ; Bchir, Fatma ; Zouiten, Amina ; Tahrani, Leyla ; Ben Mansour, Hedi</creatorcontrib><description>The present study was undertaken to report the modeling of the dosing-time-dependent adverse effects of both untreated and biologically-treated pharmaceutical wastewater in mice. The mice were housed in a room controlled at 24 °C under a 12 h/12 h dark-light cycle (light 7:00–19:00 h) for two weeks before initiating the experiments and allowed free access to food and water. A single dose of pharmaceutical or bioremediated effluent was administrated intraperitoneally (10 mL/kg) to mice divided in six circadian stages [1, 5, 9, 13, 17, and 21 hours after light onset (HALO)]. The surviving treated mice exhibited a significant circadian variation in body weight loss (p &lt; 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in −6.5% weight loss, whereas drug dosing at 9 HALO was + 1.2% (Ф = 19.42 HALO ± 1.25 h, p &lt; 0.01). Only on the dark span, the proportion of dead mice was dosing-time-dependent (χ ² = 12.7; p &lt; 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in the poorest (67%) survival rate; whereas, the best survival was noted in the rest span with 100%. Troughs of motor incoordination were located at the administration times of 9 and 21 HALO (16% of animals affected), whereas peaks were located at 5 and 17 HALO (38 and 55% of animals affected, respectively). A statistically significant ultradian component rhythm with a trial period = 12 h, was detected by cosinor (p &lt; 0.009) the Ф = 17.00 HALO ± 1.70 h modulo 12 h. The toxicity was totally removed when the mice were treated by the bioremediated effluent. This indicates that Pseudomonas putida was able to completely detoxify the toxic pharmaceutical effluent. With regards to these data, the optimal tolerance to untreated pharmaceutical wastewater occurred in the light-rest span of mice.</description><identifier>ISSN: 1744-4179</identifier><identifier>ISSN: 0929-1016</identifier><identifier>EISSN: 1744-4179</identifier><identifier>DOI: 10.1080/09291016.2013.787684</identifier><language>eng</language><publisher>Taylor &amp; Francis</publisher><subject>adverse effects ; ataxia (disorder) ; bioremediation ; body weight changes ; chronotoxicity ; circadian rhythm ; drugs ; mice ; pharmaceutical wastewater ; photoperiod ; Pseudomonas putida ; survival rate ; toxicity ; wastewater ; weight loss</subject><ispartof>Biological rhythm research, 2014-03, Vol.45 (2), p.167-181</ispartof><rights>2013 Taylor &amp; Francis 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c280t-d67a658976dd771eb82e0ce1f5b2e0a7636076c69f5114a0b1baff1140d392853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Dridi, Dorra</creatorcontrib><creatorcontrib>Bchir, Fatma</creatorcontrib><creatorcontrib>Zouiten, Amina</creatorcontrib><creatorcontrib>Tahrani, Leyla</creatorcontrib><creatorcontrib>Ben Mansour, Hedi</creatorcontrib><title>Murine chronotoxicity to pharmaceutical wastewater</title><title>Biological rhythm research</title><description>The present study was undertaken to report the modeling of the dosing-time-dependent adverse effects of both untreated and biologically-treated pharmaceutical wastewater in mice. The mice were housed in a room controlled at 24 °C under a 12 h/12 h dark-light cycle (light 7:00–19:00 h) for two weeks before initiating the experiments and allowed free access to food and water. A single dose of pharmaceutical or bioremediated effluent was administrated intraperitoneally (10 mL/kg) to mice divided in six circadian stages [1, 5, 9, 13, 17, and 21 hours after light onset (HALO)]. The surviving treated mice exhibited a significant circadian variation in body weight loss (p &lt; 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in −6.5% weight loss, whereas drug dosing at 9 HALO was + 1.2% (Ф = 19.42 HALO ± 1.25 h, p &lt; 0.01). Only on the dark span, the proportion of dead mice was dosing-time-dependent (χ ² = 12.7; p &lt; 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in the poorest (67%) survival rate; whereas, the best survival was noted in the rest span with 100%. Troughs of motor incoordination were located at the administration times of 9 and 21 HALO (16% of animals affected), whereas peaks were located at 5 and 17 HALO (38 and 55% of animals affected, respectively). A statistically significant ultradian component rhythm with a trial period = 12 h, was detected by cosinor (p &lt; 0.009) the Ф = 17.00 HALO ± 1.70 h modulo 12 h. The toxicity was totally removed when the mice were treated by the bioremediated effluent. This indicates that Pseudomonas putida was able to completely detoxify the toxic pharmaceutical effluent. With regards to these data, the optimal tolerance to untreated pharmaceutical wastewater occurred in the light-rest span of mice.</description><subject>adverse effects</subject><subject>ataxia (disorder)</subject><subject>bioremediation</subject><subject>body weight changes</subject><subject>chronotoxicity</subject><subject>circadian rhythm</subject><subject>drugs</subject><subject>mice</subject><subject>pharmaceutical wastewater</subject><subject>photoperiod</subject><subject>Pseudomonas putida</subject><subject>survival rate</subject><subject>toxicity</subject><subject>wastewater</subject><subject>weight loss</subject><issn>1744-4179</issn><issn>0929-1016</issn><issn>1744-4179</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFj11LwzAYhYMoOKf_QLB_oPNNmubjSmToFCZe6K7D2zRxla4Zacbcv7ejCt55dc7FeQ48hFxTmFFQcAuaaQpUzBjQYiaVFIqfkAmVnOecSn36p5-Ti77_hGEtgU0Ie9nFpnOZXcfQhRS-GtukQ5ZCtl1j3KB1u9RYbLM99sntMbl4Sc48tr27-skpWT0-vM-f8uXr4nl-v8wtU5DyWkgUpdJS1LWU1FWKObCO-rIaCkpRCJDCCu1LSjlCRSv0fqhQF5qpspgSPv7aGPo-Om-2sdlgPBgK5uhtfr3N0duM3gN2N2JN58NgsA-xrU3CQxuij9jZpjfFPw8344PHYPAjDsDqbRgIAJCac1p8A8sWaAc</recordid><startdate>20140304</startdate><enddate>20140304</enddate><creator>Dridi, Dorra</creator><creator>Bchir, Fatma</creator><creator>Zouiten, Amina</creator><creator>Tahrani, Leyla</creator><creator>Ben Mansour, Hedi</creator><general>Taylor &amp; Francis</general><scope>FBQ</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20140304</creationdate><title>Murine chronotoxicity to pharmaceutical wastewater</title><author>Dridi, Dorra ; Bchir, Fatma ; Zouiten, Amina ; Tahrani, Leyla ; Ben Mansour, Hedi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-d67a658976dd771eb82e0ce1f5b2e0a7636076c69f5114a0b1baff1140d392853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>adverse effects</topic><topic>ataxia (disorder)</topic><topic>bioremediation</topic><topic>body weight changes</topic><topic>chronotoxicity</topic><topic>circadian rhythm</topic><topic>drugs</topic><topic>mice</topic><topic>pharmaceutical wastewater</topic><topic>photoperiod</topic><topic>Pseudomonas putida</topic><topic>survival rate</topic><topic>toxicity</topic><topic>wastewater</topic><topic>weight loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dridi, Dorra</creatorcontrib><creatorcontrib>Bchir, Fatma</creatorcontrib><creatorcontrib>Zouiten, Amina</creatorcontrib><creatorcontrib>Tahrani, Leyla</creatorcontrib><creatorcontrib>Ben Mansour, Hedi</creatorcontrib><collection>AGRIS</collection><collection>CrossRef</collection><jtitle>Biological rhythm research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dridi, Dorra</au><au>Bchir, Fatma</au><au>Zouiten, Amina</au><au>Tahrani, Leyla</au><au>Ben Mansour, Hedi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Murine chronotoxicity to pharmaceutical wastewater</atitle><jtitle>Biological rhythm research</jtitle><date>2014-03-04</date><risdate>2014</risdate><volume>45</volume><issue>2</issue><spage>167</spage><epage>181</epage><pages>167-181</pages><issn>1744-4179</issn><issn>0929-1016</issn><eissn>1744-4179</eissn><abstract>The present study was undertaken to report the modeling of the dosing-time-dependent adverse effects of both untreated and biologically-treated pharmaceutical wastewater in mice. The mice were housed in a room controlled at 24 °C under a 12 h/12 h dark-light cycle (light 7:00–19:00 h) for two weeks before initiating the experiments and allowed free access to food and water. A single dose of pharmaceutical or bioremediated effluent was administrated intraperitoneally (10 mL/kg) to mice divided in six circadian stages [1, 5, 9, 13, 17, and 21 hours after light onset (HALO)]. The surviving treated mice exhibited a significant circadian variation in body weight loss (p &lt; 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in −6.5% weight loss, whereas drug dosing at 9 HALO was + 1.2% (Ф = 19.42 HALO ± 1.25 h, p &lt; 0.01). Only on the dark span, the proportion of dead mice was dosing-time-dependent (χ ² = 12.7; p &lt; 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in the poorest (67%) survival rate; whereas, the best survival was noted in the rest span with 100%. Troughs of motor incoordination were located at the administration times of 9 and 21 HALO (16% of animals affected), whereas peaks were located at 5 and 17 HALO (38 and 55% of animals affected, respectively). A statistically significant ultradian component rhythm with a trial period = 12 h, was detected by cosinor (p &lt; 0.009) the Ф = 17.00 HALO ± 1.70 h modulo 12 h. The toxicity was totally removed when the mice were treated by the bioremediated effluent. This indicates that Pseudomonas putida was able to completely detoxify the toxic pharmaceutical effluent. With regards to these data, the optimal tolerance to untreated pharmaceutical wastewater occurred in the light-rest span of mice.</abstract><pub>Taylor &amp; Francis</pub><doi>10.1080/09291016.2013.787684</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1744-4179
ispartof Biological rhythm research, 2014-03, Vol.45 (2), p.167-181
issn 1744-4179
0929-1016
1744-4179
language eng
recordid cdi_crossref_primary_10_1080_09291016_2013_787684
source Taylor and Francis Science and Technology Collection
subjects adverse effects
ataxia (disorder)
bioremediation
body weight changes
chronotoxicity
circadian rhythm
drugs
mice
pharmaceutical wastewater
photoperiod
Pseudomonas putida
survival rate
toxicity
wastewater
weight loss
title Murine chronotoxicity to pharmaceutical wastewater
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A45%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-fao_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Murine%20chronotoxicity%20to%20pharmaceutical%20wastewater&rft.jtitle=Biological%20rhythm%20research&rft.au=Dridi,%20Dorra&rft.date=2014-03-04&rft.volume=45&rft.issue=2&rft.spage=167&rft.epage=181&rft.pages=167-181&rft.issn=1744-4179&rft.eissn=1744-4179&rft_id=info:doi/10.1080/09291016.2013.787684&rft_dat=%3Cfao_cross%3EUS201600079441%3C/fao_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c280t-d67a658976dd771eb82e0ce1f5b2e0a7636076c69f5114a0b1baff1140d392853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true